Biomatter Raises $18 Million in Series A Funding
Biomatter says AstraZeneca, BASF and Sanofi are among more than 25 enterprise customers, and that it has delivered more than 50 custom enzymes.
Biomatter says AstraZeneca, BASF and Sanofi are among more than 25 enterprise customers, and that it has delivered more than 50 custom enzymes.